According to Nxera Pharma's latest financial reports the company has a price-to-book ratio of 3.25754.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 1.40 | -20.11% |
2023-12-31 | 1.75 | -42.07% |
2022-12-31 | 3.02 | 11.94% |
2021-12-31 | 2.70 | -2.48% |
2020-12-31 | 2.77 | -25.39% |
2019-12-31 | 3.71 | 169.29% |
2018-12-31 | 1.38 | -63% |
2017-12-31 | 3.73 | -50.12% |
2016-12-31 | 7.47 | 33.18% |
2015-12-31 | 5.61 | 41.66% |
2014-12-31 | 3.96 | -51.16% |
2013-12-31 | 8.11 | 127.51% |
2012-12-31 | 3.56 | 75.39% |
2011-12-31 | 2.03 | 18.76% |
2010-12-31 | 1.71 | 53.27% |
2009-12-31 | 1.12 | 292.9% |
2008-12-31 | 0.2840 |